CD8A and neoplasm: Others have proposed that, even though treatment with anti-PD-1/PD-L1 and anti-CTLA-4 antibodies would usually expand anti-tumor CD8 + and CD4 + T cells, such treatment might, upon certain circumstances, increase the population of PD-1 + T regs producing an effect of immunosuppression.